The 4th Annual Meeting of the International Cytokine and Interferon Society (ICIS)

国际细胞因子和干扰素学会(ICIS)第四届年会将在旧金山举行 2016年10月16日至10月19日在加利福尼亚州弗朗西斯科凯悦酒店举行。这是国际的 会议将汇聚细胞因子信号和生物学、免疫学、 癌症研究、新陈代谢和传染病。本次会议的共同主席是大卫·阿蒂斯博士 (康奈尔大学)，约翰·奥谢博士(NIH)，埃里卡·皮尔斯博士(马克斯·普朗克)；这些科学家一起涵盖了一个 具有与ICIS利益相关的广泛科学专业知识，并具有出色的工作能力 作为一个团队的关系。会议的一个主要目标将是促进科学家之间的互动 侧重于生物学不同领域中的细胞因子信号和功能，如宿主-微生物区系相互作用， 先天免疫，宿主防御，全身代谢的免疫调节，免疫中的细胞代谢 细胞、初级免疫缺陷和表观遗传学--以及这些如何转化为新的治疗方法。另一个 本次会议的目标是促进青年调查人员和受训人员与已建立的 干扰素和细胞因子领域的研究人员。杰出的初级调查人员、博士后研究人员和 将鼓励研究生/医学生参加，并将在#年向年轻的研究人员颁发奖项。 这些类别中的每一个，如本提案正文所述。除了邀请了大约34人 计划在全体会议和座谈会上发言的演讲者(一些空位仍为新手演讲者开放) 报名者提交的一些摘要将被选为专题的口头报告 会话。将特别注意让初级调查人员有机会介绍他们的工作 在这些会议期间。欢迎多达300名参赛者赠送海报，并将有机会 在他们的海报会议上讨论他们的工作。该项目包括来自学术机构的科学家， 以及来自生物技术和制药公司的。我们特别注意确保 按性别、种族、资历和地理位置进行平衡的计划。一项特别努力将是 旨在支持任职人数不足的少数群体和妇女的职业发展，也是 2016年会议将有2个讲习班和专门为受训人员和青年举办的特别招待会(一年级) 教职员工，旨在促进这些互动。这是联合主席和科学组织的坚定信念 委员会(由来自8个国家的17名科学家组成，其中包括7名女性和2名URM)，通过带来 将这些不同细胞因子研究领域的领导者、初级研究人员和受训人员聚集在一起，这次会议将 启发了重要的新的调查途径，将对职业发展大有裨益 在细胞因子领域很有前途的年轻研究人员和实习生。

The 4th Annual Meeting of the International Cytokine and Interferon Society (ICIS) will be held in San Francisco, California at the Hyatt Regency Hotel from October 16 - October 19, 2016. This international conference will bring together leading investigators in the fields of cytokine signaling and biology, immunology, cancer research, metabolism, and infectious diseases. The Co-Chairs for this meeting are Dr. David Artis (Cornell University), Dr. John O'Shea (NIH), Dr. Erika Pearce (Max Planck); together, these scientists cover a broad spectrum of scientific expertise relevant to the interests of the ICIS, and have an excellent working relationship as a group. A major goal of the meeting will be to promote the interactions between scientists focusing on cytokine signaling and function in diverse areas of biology, such as host-microbiota interactions, innate immunity, host defense, immune regulation of whole body metabolism, cellular metabolism in immune cells, primary immunodeficiencies, and epigenetics – and how these translate into emerging therapies. Another goal of this meeting is to facilitate interactions between young investigators and trainees with established researchers in the interferon and cytokine field. Outstanding junior investigators, postdoctoral researchers, and graduate/medical students will be encouraged to participate, and awards will be given to young researchers in each of these categories, as described in the body of this proposal. In addition to approximately 34 invited speakers (some slots remain open for late-breaking speakers) scheduled for Plenary Sessions and Symposia, a number of abstracts submitted by registrants will be selected for oral presentations in Special Topics Sessions. Particular attention will be paid to giving junior investigators an opportunity to present their work during these sessions. Up to 300 participants are welcome to present a poster and will be given the opportunity to discuss their work during their poster session. The program includes scientists from academic institutions, as well as from biotechnology and pharmaceutical companies. We have paid special attention to ensure a program that is well-balanced by gender, ethnicity, seniority and geographic location. A special effort will be made to support the career development of under-represented minorities and women, and an important part of the 2016 meeting is to have 2 workshops and a special reception exclusively for trainees and young (1st year) faculty, designed to foster these interactions. It is the firm belief of the Co-Chairs and Scientific Organizing Committee (composed of 17 scientists from 8 countries including 7 females and two URMs) that, by bringing together leaders, junior investigators, and trainees in these diverse areas of cytokine research, this meeting will inspire important new avenues of investigation and will be of great benefit to the career development of promising young investigators and trainees in the cytokine field.